ApoGen increases 2016 Series A funding round to $11 million
Company draws $4 million in additional funding from Merck KGaA's venture capital arm and other investors.
Artios raises $84M for developing cancer drugs targeting DNA repair pathway
The UK firm is developing drugs targeting DNA damage response, similar to approved PARP inhibitors for gynecologic cancers.
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
Medisafe raises $14.5M and adds London office to reflect growth in Europe
New European investor Octopus Ventures led the Series B round with participation from another new backer, M Ventures — the Amsterdam-based, strategic, corporate venture capital arm of Merck KGaA, in Darmstadt, Germany